Viral Hepatitis Other than A, B, and C: Evaluation and Management
- PMID: 32620280
- PMCID: PMC7152899
- DOI: 10.1016/j.cld.2020.04.008
Viral Hepatitis Other than A, B, and C: Evaluation and Management
Abstract
Viral hepatitis can cause a wide spectrum of clinical presentations from a benign form with minimal or no symptoms to acute liver failure or death. Hepatitis D coinfection and superinfection have distinct clinical courses, with the latter more likely leading to chronic infection. Management of chronic hepatitis D virus is individualized because of the paucity of treatment options and significant side effect profile of currently available treatments. Sporadic cases of hepatitis E caused by contaminated meats are becoming increasingly prevalent in immunocompromised hosts. Human herpesviruses are an important cause of disease also in immunocompromised individuals.
Keywords: Hepatitis D; Hepatitis E; Hepatotropic viruses; Human herpesvirus; Viral hepatitis.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure A. Cheung has nothing to disclose. P. Kwo has received grant support from Eiger.
Figures
References
-
- Heller T., Koh C., Glenn J.S. Hepatitis D. In: Sanyal A., Boyer T., Lindor K., editors. Zakim and Boyer's hepatology: a textbook of liver disease. 7th edition. Elsevier; Philadelphia: 2018. pp. 501–511.
-
- Lin H.H., Lee S.S., Yu M.L. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program. Hepatology. 2015;61(6):1870–1879. - PubMed
-
- Chen H.Y., Shen D., Ji D. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut. 2019;68:512–521. - PubMed
-
- Caredda F., Rossi E., d'Arminio Monforte A. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis. 1985;151(5):925–928. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
